UBS Group began coverage on shares of Elanco Animal Health (NYSE:ELAN – Free Report) in a research report report published on ...

Elanco Animal Health Inc (ELAN) stock saw a decline, ending the day at $12.42 which represents a decrease of $-0.46 or -3.57% from the prior close of $12.88. The stock opened at $12.9 and touched a ...

Fintel reports that on December 9, 2024, UBS initiated coverage of Elanco Animal Health (NYSE:ELAN) with a Buy recommendation ...

Technical analysis for Elanco Animal Health Incorporated ELAN including support levels resistance levels and stop losses for ELAN ...

UBS initiated coverage of Elanco (ELAN) with a Buy rating and $18 price target The shares are down 19% year-to-date and 7% last week alone on ...

Fmr LLC decreased its holdings in shares of Elanco Animal Health Incorporated (NYSE:ELAN – Free Report) by 6.6% during the ...

Elanco is an animal health company that develops, manufactures, and markets products for pets and farm animals. The Company is developing, among other drugs, Zenrelia, a "safe, highly effective, and ...

Elanco Animal Health Inc (ELAN) stock saw a decline, ending the day at $12.12 which represents a decrease of $-0.13 or -1.06% from the prior close of $12.25. The stock opened at $12.3 and touched a ...

Bovaer is a new feed additive that claims to significantly reduce the emission of methane, a greenhouse gas that is driving climate change, in dairy cows.

The Shareholders Foundation, Inc. announces that a lawsuit is currently pending for certain investors in shares of Elanco Animal Health Incorporated ...